- Home
- GWRE vs DGX Comparison
GWRE vs DGX Comparison
Compare GWRE & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GWRE
- DGX
- Stock Information
- Founded
- GWRE 2001
- DGX 1967
- Country
- GWRE United States
- DGX United States
- Employees
- GWRE N/A
- DGX N/A
- Industry
- GWRE Computer Software: Prepackaged Software
- DGX Medical Specialities
- Sector
- GWRE Technology
- DGX Health Care
- Exchange
- GWRE Nasdaq
- DGX Nasdaq
- Market Cap
- GWRE 20.6B
- DGX 20.5B
- IPO Year
- GWRE 2012
- DGX 1996
- Fundamental
- Price
- GWRE $252.88
- DGX $178.30
- Analyst Decision
- GWRE Buy
- DGX Buy
- Analyst Count
- GWRE 14
- DGX 15
- Target Price
- GWRE $270.77
- DGX $194.07
- AVG Volume (30 Days)
- GWRE 603.1K
- DGX 1.1M
- Earning Date
- GWRE 12-04-2025
- DGX 10-21-2025
- Dividend Yield
- GWRE N/A
- DGX 1.78%
- EPS Growth
- GWRE N/A
- DGX 14.49
- EPS
- GWRE 0.81
- DGX 8.51
- Revenue
- GWRE $1,202,459,000.00
- DGX $10,850,000,000.00
- Revenue This Year
- GWRE $18.42
- DGX $11.17
- Revenue Next Year
- GWRE $14.96
- DGX $3.48
- P/E Ratio
- GWRE $306.44
- DGX $21.17
- Revenue Growth
- GWRE 22.64
- DGX 13.74
- 52 Week Low
- GWRE $165.09
- DGX $148.70
- 52 Week High
- GWRE $272.60
- DGX $197.55
- Technical
- Relative Strength Index (RSI)
- GWRE 63.67
- DGX 40.36
- Support Level
- GWRE $248.50
- DGX $179.53
- Resistance Level
- GWRE $255.40
- DGX $184.73
- Average True Range (ATR)
- GWRE 5.29
- DGX 3.97
- MACD
- GWRE 1.08
- DGX -0.82
- Stochastic Oscillator
- GWRE 88.84
- DGX 4.36
About GWRE Guidewire Software Inc.
Guidewire Software provides cloud-based software solutions for property and casualty insurers. The flagship product, InsuranceSuite is a system of record and comprises ClaimCenter, a claims management system; PolicyCenter, a policy management system including policy definitions, quotas, issuance, maintenance, and renewal; and BillingCenter, for billing management, payment plans, and agent commissions. The company also offers InsuranceNow, a midmarket offering, as well as a variety of other add-on applications and services.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.